Erelzi RSS feed1440Copyright: (C) European Medicines Agencyen-gbThu, 13 Jul 2017 18:17:29 +0100http://www.ema.europa.euErelzi RSS feedHuman medicines European Public Assessment Report (EPAR): Erelzi, etanercept, Revision: 0, Authorisedhttp://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004192/human_med_002112.jsp&mid=WC0b01ac058001d124http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004192/human_med_002112.jsp&mid=WC0b01ac058001d124Thu, 29 Jun 2017 00:00:00 +0100Erelzi : EPAR - Public assessment reporthttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004192/WC500230144.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004192/WC500230144.pdfThu, 29 Jun 2017 00:00:00 +0100Erelzi : EPAR - Product Informationhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004192/WC500230142.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004192/WC500230142.pdfThu, 29 Jun 2017 00:00:00 +0100Erelzi : EPAR - All Authorised presentationshttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004192/WC500230143.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004192/WC500230143.pdfThu, 29 Jun 2017 00:00:00 +0100Erelzi : EPAR - Summary for the publichttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004192/WC500230145.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004192/WC500230145.pdfThu, 29 Jun 2017 00:00:00 +0100CHMP summary of positive opinion for Erelzihttp://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004192/WC500226158.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004192/WC500226158.pdfFri, 21 Apr 2017 00:00:00 +0100News and Press Releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 April 2017http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002732.jsp&mid=WC0b01ac058004d5c1http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002732.jsp&mid=WC0b01ac058004d5c1Fri, 21 Apr 2017 00:00:00 +0100